How to conduct a cost analysis of quality improvements in TB labs
Quality improvement in a tuberculosis laboratory is often presented as a technical or compliance exercise, yet every change uses scarce resources. A new biosafety measure may require equipment and training. Better documentation may increase staff time at first. A preventive maintenance schedule can create planned costs while reducing instrument downtime and repeat testing.
A cost analysis makes these trade-offs visible. It helps laboratory managers compare current practices with a proposed quality improvement, estimate the resources required, and determine whether the change produces worthwhile operational and public health benefits. The analysis does not need to be complicated or depend on sophisticated financial software.
For laboratories working in different resource settings, the most useful approach is practical, transparent, and linked to the quality management system. Costs can be recorded in local currency, converted to a common currency when necessary, and updated as prices, workload, or testing platforms change.
Define the decision and baseline
Begin by stating the decision that the analysis will support. Examples include introducing a stock management system, improving GeneXpert operator training, adding equipment maintenance, strengthening internal quality control, or redesigning the specimen referral process. A clear decision prevents the exercise from becoming a general list of laboratory expenses.
Next, describe the baseline. Record how the laboratory currently performs the activity, including staff involved, equipment used, testing volume, error rates, rejected specimens, stockouts, repeat tests, turnaround time, and instrument downtime. Existing registers, procurement records, maintenance logs, quality indicators, and staff interviews are useful sources.
The baseline should cover a defined period, such as six or twelve months. If the laboratory has incomplete records, document the assumptions used. For example, a manager may estimate the average number of tests repeated because of an invalid result from daily bench records and quality control reports. Transparent assumptions are more valuable than false precision.
Identify resources and assign costs
List every resource needed for the quality improvement. Direct costs may include reagents, controls, personal protective equipment, calibration services, training materials, external assessment fees, software, printing, and minor equipment. Staff time is also a cost, even when personnel are already employed. Estimate time spent attending training, completing forms, checking temperatures, reviewing errors, or conducting corrective actions.
Separate one-time costs from recurring costs. A biosafety cabinet, barcode printer, or initial training workshop may be purchased once, while consumables, maintenance contracts, refresher training, and quality control materials recur. If equipment will be used for several years, annualize its cost by spreading the purchase price across its expected useful life. Include installation, shipping, import duties, validation, and disposal where they apply.
Use actual local prices whenever possible. Procurement invoices, framework agreements, supplier quotations, payroll records, and transport receipts can provide realistic figures. When costs are shared across services, allocate them using a defensible basis, such as the proportion of tests performed, staff time used, or instrument hours. Avoid assigning the full cost of a shared resource to one TB testing activity.
Measure the value of quality improvements
Quality improvements create value through several pathways. Fewer contaminated or rejected specimens reduce repeat collection and testing. Better inventory control prevents emergency purchases and expired stock. Preventive maintenance reduces downtime and the need to refer specimens elsewhere. Improved competency can lower invalid results, transcription errors, and delays in reporting.
Translate these effects into measurable outcomes. Useful indicators include cost per valid result, cost per correctly reported result, invalid-test rate, stockout days, reagent wastage, turnaround time, equipment availability, corrective action closure time, and the number of tests referred to another facility. A public health benefit may also arise when faster, reliable results support earlier treatment and reduce unnecessary diagnostic delays.
Some benefits are financial, while others are operational or clinical. A laboratory may not be able to assign a monetary value to every avoided delay or improved staff confidence. In that situation, present financial results alongside service indicators rather than excluding important outcomes. A quality improvement can be justified by improved reliability even when direct savings are modest.
For reagent availability, the practical guidance on managing reagent stockouts can help laboratories identify avoidable interruptions and the resources required to prevent them. The resulting stockout data can be included in both the baseline and the projected improvement scenario.
Compare current practice with proposed change
A simple cost-effectiveness analysis compares the additional cost of an intervention with the additional improvement it produces. The calculation can be expressed as:
Incremental cost-effectiveness ratio = (cost after improvement − baseline cost) ÷ (outcome after improvement − baseline outcome)
The outcome might be one additional valid result, one percentage-point reduction in invalid tests, one day of avoided stockout, or one correctly completed corrective action. Use an outcome that laboratory staff can measure consistently and that matters to the decision.
Avoid assuming that every improvement will reduce total spending. Some interventions increase short-term expenditure because they require training, supervision, or higher-quality materials. The relevant question is whether the added cost is reasonable compared with the quality gain and the risks reduced. Include avoided costs such as repeat testing, emergency procurement, sample referral, instrument repair, staff overtime, and wasted reagents.
| Quality improvement | Main cost categories | Possible savings or gains | Useful indicators |
|---|---|---|---|
| Inventory control and reorder levels | Staff time, stock cards or software, training, monthly reviews | Fewer stockouts, emergency purchases, and expired reagents | Stockout days, wastage rate, emergency orders |
| Preventive equipment maintenance | Service contract, spare parts, staff coordination, downtime during service | Fewer breakdowns, repeat tests, and referred specimens | Instrument availability, error codes, referral volume |
| Competency-based staff training | Trainer time, materials, staff release time, assessment | Fewer invalid results and reporting errors | Competency scores, invalid-test rate, corrected reports |
| Internal quality control strengthening | Control materials, documentation, review time | Earlier detection of assay or procedural problems | QC failures, corrective action closure, repeat testing |
| Specimen workflow redesign | Layout changes, labels, transport materials, staff orientation | Faster processing and fewer rejected specimens | Rejection rate, turnaround time, pending specimens |
Account for training, safety, and implementation
Training costs are frequently underestimated because managers count only the course fee. Include preparation, trainer time, staff travel, venue costs, per diem, replacement staff, competency assessment, follow-up supervision, and refresher sessions. A training intervention may fail to deliver its expected benefit if staff lack access to functioning instruments, current standard operating procedures, or routine feedback.
For GeneXpert services, operator competency should be linked to the full workflow rather than a single demonstration. The resource on GeneXpert staff training can inform the activities and time requirements that belong in the estimate. Costs may include cartridge handling practice, result interpretation, error management, biosafety, data recording, and post-training assessment.
Safety improvements deserve the same financial discipline. Consider the cost of engineering controls, respiratory protection, spill response supplies, waste treatment, vaccination or medical surveillance where applicable, and staff time for safety drills. Benefits can include fewer exposures, reduced interruption after incidents, better compliance, and protection of the workforce. These outcomes may be difficult to monetize, so document them explicitly in the decision record.
Test assumptions and plan for uncertainty
Cost estimates are affected by workload, exchange rates, supplier prices, staff turnover, equipment lifespan, and the actual effect of the intervention. Build at least two scenarios, such as expected and conservative. For example, calculate results if an inventory intervention reduces stockout days by 30 percent and again if it reduces them by 10 percent. This sensitivity analysis shows whether the decision remains reasonable when the expected benefit is smaller than planned.
Check which assumptions have the greatest influence on the result. In a high-volume laboratory, a small reduction in invalid tests may create substantial savings. In a low-volume setting, training and equipment costs may dominate. A shared instrument may appear inexpensive per test at high utilization but costly when workload is low. Record the workload threshold at which the improvement becomes financially attractive.
Use a time horizon that matches the intervention. A short-term analysis may be appropriate for a training activity, while equipment or facility improvements should be examined over several years. Discounting may be required for formal economic evaluations, but a straightforward annual cash-flow view is often sufficient for local management decisions.
Integrate findings into the quality system
A cost analysis should support the laboratory’s quality management activities rather than sit in a separate finance document. Map each proposed improvement to relevant Quality Systems Essentials, such as equipment, personnel, purchasing and inventory, documents and records, assessment, facilities and safety, or continual improvement. This shows how expenditure addresses a recognized quality risk.
The GLI Quality Tool provides practical quality guidance through a phased roadmap, checklists, user instructions, and materials that can help organize this process. A laboratory can use the relevant phase and checklist to define the improvement, identify gaps, estimate resources, assign responsibility, and monitor results.
Present the findings in a brief decision paper. Include the baseline, intervention, time horizon, cost categories, assumptions, expected outcomes, risks, and indicators. After implementation, compare actual costs and results with the forecast. If the improvement performs differently than expected, update the estimate and record the lesson as part of continual improvement.
Recommended practices for credible analysis
- Use a consistent costing period and document every assumption, data source, and allocation rule.
- Separate one-time investment costs from recurring operating costs and staff time.
- Compare baseline and post-improvement results using the same definitions and indicators.
- Include avoided costs, service reliability, safety, and public health value alongside direct savings.
- Review the analysis after implementation and revise future budgets using actual laboratory data.
A well-prepared cost analysis gives TB laboratory leaders a defensible basis for prioritizing quality improvements. Start with one defined problem, gather reliable baseline information, price the full intervention, and monitor the outcomes that matter to patients, staff, and laboratory operations. Use the resulting evidence to guide funding decisions and embed the chosen improvement into routine quality management.